Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Completed · Not applicable

Conditions studied: HIV Infections

In brief

The purpose of this study is to see if it is safe and effective to treat HIV-infected patients with indinavir (IDV) plus nelfinavir (NFV), 2 anti-HIV medications. It is thought that IDV plus NFV will be a safe drug combination for treating HIV.

Key facts

Study ID

NCT00002375

Run by

Merck Sharp & Dohme LLC

People needed

24

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You may be eligible for this study if you:
• Are HIV-positive.
• Have a CD4 count of at least 100 cells/mm3.
• Have a plasma viral load (level of HIV in the blood) of at least 30,000 copies/ml.
• Are at least 18 years old.

You may not qualify if…

• You will not be eligible for this study if you:
• Have ever been treated with any protease inhibitors (PIs).

Where it is running

• Univ of Alabama at Birmingham — Birmingham, Alabama, United States
• UCSD Treatment Ctr / Dept of Medicine and Pediatrics — San Diego, California, United States
• Univ of Pittsburgh / Graduate School of Public Health — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.